MARCKS Peptide (151-175), Phosphorylated
MARCKS Peptide (151-175), Phosphorylated is a phosphorylated peptide corresponding to the basic effector domain of myristoylated alanine-rich protein kinase C substrate protein (MARCKS) . Phosphorylation of MARCKS Peptide (151-175) reverses its inhibition of phospholipase C (PLC) -catalyzed hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) [1].
Product Specifications
UNSPSC
12352209
Target
MARCKS
Type
Peptides
Related Pathways
Cytoskeleton
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/marcks-peptide-151-175-phosphorylated.html
Solubility
10 mM in DMSO
Smiles
O=C([C@@H](N)CCCCN)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)CCCCNC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC1=CC=CC=C1)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](N)CC2=CC=CC=C2)=O)CCCCN)=O)CCCCN)=O)CC(N)=O)=O)CCCCN)=O)CCCCN)=O)COP(O)(O)=O)=O)=O)CCCCN)=O)CC(C)C)=O)CO)=O)=O)CC3=CC=CC=C3)=O)COP(O)(O)=O)=O)=O)CCCCN)=O)CC4=CC=CC=C4)=O)COP(O)(O)=O)=O)CC5=CC=CC=C5)=O)CCCNC(N)=N)=O)CCCCN)=O)CCCCN)=O)CCCCN)=O)CCCCN
Molecular Formula
C147H246N41O40P3
Molecular Weight
3320.70
References & Citations
[1]Glaser M, et al. Myristoylated alanine-rich C kinase substrate (MARCKS) produces reversible inhibition of phospholipase C by sequestering phosphatidylinositol 4,5-bisphosphate in lateral domains..J Biol Chem. 1996 Oct 18;271 (42) :26187-93.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog